PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-51.02%
Negative revenue growth while ON stands at 1.59%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-46.54%
Negative gross profit growth while ON is at 87.85%. Joel Greenblatt would examine cost competitiveness or demand decline.
-9.60%
Negative EBIT growth while ON is at 138.01%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-55.20%
Negative operating income growth while ON is at 133.71%. Joel Greenblatt would press for urgent turnaround measures.
80.95%
Net income growth at 50-75% of ON's 135.03%. Martin Whitman would question fundamental disadvantages in expenses or demand.
81.13%
EPS growth at 50-75% of ON's 135.65%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
81.13%
Diluted EPS growth at 50-75% of ON's 135.65%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
0.19%
Slight or no buybacks while ON is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.19%
Slight or no buyback while ON is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-3.21%
Dividend reduction while ON stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
316.99%
Positive OCF growth while ON is negative. John Neff would see this as a clear operational advantage vs. the competitor.
184.15%
Positive FCF growth while ON is negative. John Neff would see a strong competitive edge in net cash generation.
-28.67%
Negative 10Y revenue/share CAGR while ON stands at 71.75%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-39.49%
Negative 5Y CAGR while ON stands at 19.72%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-62.42%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
64.38%
5Y OCF/share CAGR above 1.5x ON's 17.99%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
39.55%
Positive 3Y OCF/share CAGR while ON is negative. John Neff might see a big short-term edge in operational efficiency.
-185.06%
Negative 10Y net income/share CAGR while ON is at 245.86%. Joel Greenblatt sees a major red flag in long-term profit erosion.
70.38%
Below 50% of ON's 12132.26%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-115.93%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
91.70%
Below 50% of ON's 411.86%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
88.43%
5Y equity/share CAGR at 50-75% of ON's 142.72%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
33.93%
3Y equity/share CAGR at 50-75% of ON's 54.30%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
1.01%
Dividend/share CAGR of 1.01% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
19.89%
Dividend/share CAGR of 19.89% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
42.45%
3Y dividend/share CAGR of 42.45% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-17.25%
Firm’s AR is declining while ON shows 12.36%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-29.91%
Inventory is declining while ON stands at 0.43%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-2.06%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-0.62%
We have a declining book value while ON shows 0.51%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
6.74%
Debt growth far above ON's 0.13%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-55.80%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-10.69%
We cut SG&A while ON invests at 1.18%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.